Hoth Therapeutics (NASDAQ:HOTH) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen downgraded shares of Hoth Therapeutics (NASDAQ:HOTH – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. Separately, D. Boral Capital reiterated a “buy” rating and set a $5.00 price objective on shares of Hoth Therapeutics in a research note on Thursday, […]
Wall Street Zen downgraded shares of Hoth Therapeutics (NASDAQ:HOTH – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday morning. Separately, D. Boral Capital reiterated a “buy” rating and set a $5.00 price objective on shares of Hoth Therapeutics in a research note on Thursday, […]
